Search for Hidden Infections Case Scenario Prof. Dr Se… — Transcript

Full Transcript — Download SRT & Markdown

00:00
Speaker A
عبد الرحمن 10 years old boy complaining of two painful erythematous skin nodules on his chest wall appeared one and a half year ago.
00:09
Speaker A
بس هي بقى لها سنه ونص يعني ظاهره
00:14
Speaker A
not associated with axillary swelling or any other swelling.
00:19
Speaker A
عملنا له biopsy من 6 شهور وطلع فيه scar
00:24
Speaker A
Another nodule appeared on lower abdomen. Condition wasn't associated with fever. Patient generally looks healthy, good built.
00:36
Speaker A
بس هو ده اللي احنا عملناه في الاول
00:38
Speaker A
Lower abdomen skin nodule changed to a black eschar on a red plaque then disappeared totally.
00:44
Speaker A
His back also showed macular rashes which disappeared spontaneously.
00:55
Speaker A
بعد كده عملنا له بقى ال investigations done according to the biopsy result.
00:57
Speaker A
The patient has already done tuberculin test which was negative and CT chest which was also normal at chest hospital.
01:04
Speaker A
then was referred to us. BCG scar not found.
01:49
Speaker A
طبعا انا يعني حولت اخش في ال diagnosis of lupus vulgaris
01:57
Speaker A
فحاولت اطبق عليه ال investigations بتاعته
02:11
Speaker A
Is it Lupus Vulgaris?
02:12
Speaker A
Lupus vulgaris is a chronic and progressive form of cutaneous tuberculosis that represents a reactivation of infection in people with moderate to high immunity against the bacillus.
02:18
Speaker A
It may occur either as a result of direct extension from an underlying focus or via lymphatic or hematogenous spread.
02:24
Speaker A
Without therapy, lesions of lupus vulgaris persist for years, and the plaques may grow to enormous sizes.
02:28
Speaker A
In addition, ulceration and destruction of underlying tissues may occur, causing severe disfigurement.
02:34
Speaker A
Lupus vulgaris usually begins as a collection of discrete, red-brown papules that subsequently coalesce to form an indolent, asymptomatic plaque.
02:40
Speaker A
The plaque gradually reaches a size of 0.5-10 cm and develops central clearing and atrophy.
02:45
Speaker A
The borders may acquire a serpiginous or verrucous quality. Hypertrophic, ulcerative and vegetative forms of lupus vulgaris may also occur.
02:52
Speaker A
In Western countries, lesions often develop on the head and neck.
02:56
Speaker A
In (sub)tropical areas, lesions are commonly found on the lower extremities or buttocks.
03:01
Speaker A
Is it Lupus Vulgaris?
03:03
Speaker A
Differential diagnosis of lupus vulgaris can be other forms of cutaneous TB, deep fungal infections, leishmaniasis, sarcoidosis.
03:09
Speaker A
hypertrophic lichen planus, lichen simplex chronicus, blastomycosis.
03:13
Speaker A
Lesions on the nose can mimic lepromatous leprosy, Wegener's granulomatosis and syphilis.
03:19
Speaker A
Investigations done through our clinic: Abdominal ultrasound and chest x-ray normal.
03:23
Speaker A
CT chest and abdomen with contrast normal. CT paranasal sinuses variable degree of pansinusitis.
03:29
Speaker A
CBC normal.
03:31
Speaker A
ESR 15 mm.
03:34
Speaker A
LDH 204 U/L (110-295).
03:38
Speaker A
ACE 99 U/L (8-52).
03:41
Speaker A
Total calcium 9.5 mg/dl.
03:44
Speaker A
Serum Quantiferon TB Gold negative.
03:47
Speaker A
Serum galactomannan 1 (positive >=0.5) which is quite sensitive.
03:52
Speaker A
Random blood sugar 78 mg/dl.
03:55
Speaker A
HbA1c 5.4.
03:57
Speaker A
HIV negative.
03:59
Speaker A
Dermatology consultation with senior staff and revision of slide pathology.
04:04
Speaker A
Rheumatology and immunology consultations.
04:07
Speaker A
Eye examination and slit lamp normal.
04:10
Speaker A
CT scans with contrast.
04:12
Speaker A
CT paranasal sinuses.
04:15
Speaker A
Chronological Lymphocytic count Follow up.
04:18
Speaker A
3/2022: 1140. ESR 37, 70. LDH 944.
04:22
Speaker A
7/2023: 1161. CD4 low? CD8 low?
04:26
Speaker A
1/2024: 2576. ESR 66, 115.
04:30
Speaker A
3/2024: 3402. ESR 15. LDH 204.
04:35
Speaker A
What causes transient lymphopenia and immunodysregulation?
04:40
Speaker A
Rare Case of Persistently Depressed T Lymphocyte Subsets After SARS-CoV-2 Infection.
04:44
Speaker A
Male, 82-year-old. Final Diagnosis: A rare case of persistently depressed T lymphocyte subsets post COVID-19 infection.
04:48
Speaker A
Symptoms: Shortness of breath. Medication: ---.
04:51
Speaker A
Clinical Procedure: ---. Specialty: Immunology + Infectious Diseases.
04:54
Speaker A
Objective: Unusual clinical course.
04:56
Speaker A
Background: On rare occasions, viral infections are known to also depress immune cell lines, further worsening clinical outcomes.
05:01
Speaker A
We describe a patient who presented 3 weeks after recovery from mild COVID-19 disease with clinical features of an atypical pneumonia.
05:06
Speaker A
and was found to have a low CD4+ T-cell count.
05:09
Speaker A
An 82-year-old man with a past medical history of coronary artery disease, rheumatoid arthritis, gout, hypertension, and atrial fibrillation.
05:16
Speaker A
presented with a 1-week history of progressively worsening shortness of breath and cough.
05:20
Speaker A
He was noted to have recovered from mild SARS-CoV-2 infection 3 weeks prior to his current presentation.
05:25
Speaker A
and had been at his baseline level of health following infection.
05:28
Speaker A
A T cell subset panel was obtained, which revealed an absolute CD3 count of 92.
05:34
Speaker A
(reference range 840-3060), absolute CD4 count of 52 (reference range 500-1400).
05:40
Speaker A
absolute CD8 count of 37 (reference range 180-1170), and a normal CD4:CD8 ratio.
05:45
Speaker A
He was subsequently started on atovaquone for pneumocystis jirovecii pneumonia prophylaxis.
05:49
Speaker A
Conclusion: This case highlights the need for a high index of suspicion for lymphocyte depletion in older patients with multiple comorbidities.
05:55
Speaker A
who present during or after SARS-CoV-2 infection with atypical symptoms that are suggestive of immunosuppression.
06:00
Speaker A
In such instances, there should be a low threshold to start prophylactic therapy for possible opportunistic infections.
06:06
Speaker A
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.
06:11
Speaker A
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection develop post-acute COVID syndrome (long COVID (LC)).
06:18
Speaker A
lasting longer than 12 weeks. Here, we studied individuals with LC compared to age- and gender-matched recovered individuals without LC.
06:25
Speaker A
unexposed donors and individuals infected with other coronaviruses.
06:28
Speaker A
Patients with LC had highly activated innate immune cells, lacked naive T and B cells and showed elevated expression of type I IFN (IFN-β) and type III IFN (IFN-λ1) that remained persistently high at 8 months after infection.
06:38
Speaker A
Using a log-linear classification model, we defined an optimal set of analytes that had the strongest association with LC among the 28 analytes.
06:45
Speaker A
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2.
06:50
Speaker A
Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.
06:55
Speaker A
yet its etiology remains poorly understood. We used 'omic' assays and serology to deeply characterize the global and SARS-CoV-2-specific immunity.
07:02
Speaker A
in the blood of individuals with clear LC and non-LC clinical trajectories, 8 months postinfection.
07:06
Speaker A
We found that LC individuals exhibited systemic inflammation and immune dysregulation.
07:10
Speaker A
This was evidenced by global differences in T cell subset distribution implying ongoing immune responses.
07:14
Speaker A
as well as by sex-specific perturbations in cytolytic subsets.
07:17
Speaker A
LC individuals displayed increased frequencies of CD4+ T cells poised to migrate to inflamed tissues and exhausted SARS-CoV-2-specific CD8+ T cells.
07:24
Speaker A
higher levels of SARS-CoV-2 antibodies and a mis-coordination between their SARS-CoV-2-specific T and B cell responses.
07:29
Speaker A
Our analysis suggested an improper crosstalk between the cellular and humoral adaptive immunity in LC, which can lead to immune dysregulation.
07:35
Speaker A
inflammation and clinical symptoms associated with this debilitating condition.
07:40
Speaker A
Positive history of frequent playing in farms (soil).
07:43
Speaker A
Primary cutaneous Aspergillosis infection in immunocompetent host??
07:48
Speaker A
Lesions include single or multiple red or violet hardened plaques, nodules, or papules at the site of skin injury.
07:53
Speaker A
The lesions may be tender or symptom-free. As the lesions evolve, pus- or blood-filled blisters develop in the center.
07:59
Speaker A
which eventually become necrotic blacken ulcers or scabs. Lesions most commonly appear on the limbs and head.
08:05
Speaker A
and may affect a small or large area.
08:09
Speaker A
Table 1 Studies on Primary Cutaneous Aspergillosis Caused by Aspergillus fumigatus, in Order of Publication and First Author.
08:14
Speaker A
Mowat, 31 M/H, USA, Unknown, No, Arm, 1.2-cm hemorrhagic bulla, IV site, Amphotericin, 1 mo.
08:20
Speaker A
Camus, 37 F/M, France, Farmer, No, Cheek, eyebrow, palpebra superior, erythematous nodules, Oral ITZ 400 mg/d 15 d.
08:26
Speaker A
Sharma, 63 F/M, India, Farmer, No, Extremities, back, trunk, forehead, nodules plaques, Oral ITZ 200 mg/d 4 wk.
08:32
Speaker A
Klieger, 24 F/M, Finland, Welder, No, Back, purpuric necrotic papules, pustules evolving into crusts, Tattoo, Oral VCZ, local TER, 4wk.
08:39
Speaker A
surgical revision of necrotic tissue. Rocha, 50 F/M, India, Worker, No, Elbow, 4 x 4 cm cystic swelling, Trauma, Oral ITZ 200 mg/d 4 wk.
08:45
Speaker A
Liu, 9 M/H, China, Unemployed, No, Cheek, erythematous plaque covered with flava eschar, Trauma, Oral ITZ 75 mg/d, CPX ointment.
08:51
Speaker A
Rachana, 65 F/H, India, Farmer, MI, Left upper limb and trunk, swelling with pain, tightening of the skin, vesicles with watery discharge, Trauma, ITZ, 2 mo.
08:58
Speaker A
Mada, 80 M/H, USA, Farmer, BCC, Right ear, erythematous swelling, Surgery, Oral VCZ 200mg/12h, 4wk, incision and drainage.
09:05
Speaker A
Fan, 68 F/M, China, Unknown, Gout, HTN, Back of hand, erythematous erythema with ulceration and exudation, IV VCZ 200 mg q12h, 25 d.
09:13
Speaker A
Primary Cutaneous Aspergillosis Due to Aspergillus fumigatus in an Immunocompetent Patient with Diabetes Mellitus After Tattooing: A Case Report and Review of Literature.
09:20
Speaker A
A 46-year-old woman presented with erythematous papules, papulopustules, and a plaque on the right lower limb of more than two years duration without other symptoms.

Frequently Asked Questions

ما هي الأعراض الأولية التي ظهرت على عبد الرحمن؟

اشتكى عبد الرحمن، وهو صبي يبلغ من العمر 10 سنوات، من وجود عقدتين جلديتين مؤلمتين ومحمرتين على جدار صدره، ظهرتا قبل عام ونصف. لم تكن هذه العقد مرتبطة بتورم إبطي أو أي تورم آخر.

ما هي نتائج الفحوصات الأولية التي أجريت لعبد الرحمن قبل إحالته؟

أجريت له خزعة قبل 6 أشهر وظهرت ندبة. كما أجرى اختبار التوبركولين الذي كان سلبيًا، وأشعة مقطعية على الصدر كانت طبيعية في مستشفى الصدر.

ما هو مرض الذئبة الشائعة (Lupus Vulgaris) وما هي بعض خصائصه؟

الذئبة الشائعة هي شكل مزمن ومتقدم من السل الجلدي، يمثل إعادة تنشيط للعدوى لدى الأشخاص الذين لديهم مناعة متوسطة إلى عالية ضد العصية. قد تظهر الآفات كحطاطات حمراء بنية منفصلة تتجمع لتشكل لويحة بطيئة النمو وغير مؤلمة، ويمكن أن تسبب تشوهًا شديدًا إذا لم تعالج.

Get More with the Söz AI App

Transcribe recordings, audio files, and YouTube videos — with AI summaries, speaker detection, and unlimited transcriptions.

Or transcribe another YouTube video here →